个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
周五盘中交易时段,12只医疗保健类股走势
Gainers
- Palisade Bio (NASDAQ:PALI) shares increased by 111.8% to $6.82 during Friday's regular session. The current volume of 67.8 million shares is 4351.8% of Palisade Bio's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $9.7 million.
- Dermata Therapeutics (NASDAQ:DRMA) shares increased by 80.34% to $0.36. As of 12:30 EST, this security is trading at a volume of 37.6 million shares, making up 4522.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.3 million.
- F-star Therapeutics (NASDAQ:FSTX) stock moved upwards by 45.96% to $5.97. As of 12:30 EST, F-star Therapeutics's stock is trading at a volume of 2.9 million, which is 934.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $131.2 million.
- 180 Life Sciences (NASDAQ:ATNF) shares increased by 37.33% to $2.6. Trading volume for 180 Life Sciences's stock is 16.8 million as of 12:30 EST. This is 1149.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.7 million.
- Kala Pharmaceuticals (NASDAQ:KALA) stock rose 35.86% to $33.75. Trading volume for this security as of 12:30 EST is 11.2 million, which is 765.9% of its average full-day volume over the last 100 days. The company's market cap stands at $53.8 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.05% to $1.57. Salarius Pharmaceuticals's stock is trading at a volume of 240.1K shares as of 12:30 EST. This is 478.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.5 million.
Losers
- Hoth Therapeutics (NASDAQ:HOTH) shares fell 25.4% to $8.0 during Friday's regular session. Trading volume for Hoth Therapeutics's stock is 4.7 million as of 12:30 EST. This is 798.3% of its average full-day volume over the last 100 days. The company's market cap stands at $10.4 million.
- Nuwellis (NASDAQ:NUWE) stock fell 16.92% to $10.07. As of 12:30 EST, Nuwellis's stock is trading at a volume of 405.9K, which is 184.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 million.
- Revelation Biosciences (NASDAQ:REVBU) shares declined by 16.67% to $0.2.
- Reshape Lifesciences (NASDAQ:RSLS) shares decreased by 16.28% to $6.43. Reshape Lifesciences's stock is trading at a volume of 81.1K shares as of 12:30 EST. This is 285.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million.
- Summit Therapeutics (NASDAQ:SMMT) shares fell 13.38% to $4.6. As of 12:30 EST, this security is trading at a volume of 3.1 million shares, making up 37.6% of its average full-day volume over the last 100 days. The company's market cap stands at $926.0 million.
- Femasys (NASDAQ:FEMY) stock fell 13.15% to $0.72. The market value of their outstanding shares is at $8.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- Palisade Bio (NASDAQ:PALI) shares increased by 111.8% to $6.82 during Friday's regular session. The current volume of 67.8 million shares is 4351.8% of Palisade Bio's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $9.7 million.
- Dermata Therapeutics (NASDAQ:DRMA) shares increased by 80.34% to $0.36. As of 12:30 EST, this security is trading at a volume of 37.6 million shares, making up 4522.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.3 million.
- F-star Therapeutics (NASDAQ:FSTX) stock moved upwards by 45.96% to $5.97. As of 12:30 EST, F-star Therapeutics's stock is trading at a volume of 2.9 million, which is 934.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $131.2 million.
- 180 Life Sciences (NASDAQ:ATNF) shares increased by 37.33% to $2.6. Trading volume for 180 Life Sciences's stock is 16.8 million as of 12:30 EST. This is 1149.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.7 million.
- Kala Pharmaceuticals (NASDAQ:KALA) stock rose 35.86% to $33.75. Trading volume for this security as of 12:30 EST is 11.2 million, which is 765.9% of its average full-day volume over the last 100 days. The company's market cap stands at $53.8 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.05% to $1.57. Salarius Pharmaceuticals's stock is trading at a volume of 240.1K shares as of 12:30 EST. This is 478.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.5 million.
- Palisade Bio 纳斯达克股票代码:PALI)的股价在周五的例行交易中上涨了111.8%,至6.82美元。目前的6,780万股成交量是Palisade Bio过去100天(上次更新时间为美国东部标准时间 12:30)平均全日成交量的4351.8%。该公司的市值为970万美元。
- Dermata Therapeu 纳斯达克股票代码:DRMA)的股价上涨了80.34%,至0.36美元。截至美国东部标准时间 12:30,该证券的交易量为3,760万股,占其过去100天平均全日交易量的4522.6%。他们已发行股票的市值为430万美元。
- F-star Therap 纳斯达克股票代码:FSTX)的股票上涨了45.96%,至5.97美元。截至美国东部标准时间 12:30,F-star Therapeutics的股票交易量为290万股,占其过去100天平均全日交易量的934.6%。他们已发行股票的市值为1.312亿美元。
- 180 生命科学 纳斯达克股票代码:ATNF)的股价上涨了37.33%,至2.6美元。截至美国东部标准时间 12:30,180 Life Sciences股票的交易量为1,680万股。这是其过去 100 天平均全日交易量的1149.2%。他们已发行股票的市值为970万美元。
- 卡拉制药 纳斯达克股票代码:KALA)股价上涨35.86%,至33.75美元。截至美国东部标准时间 12:30,该证券的交易量为1,120万,占其过去100天平均全日交易量的765.9%。该公司的市值为5,380万美元。
- 萨拉里乌斯制药 纳斯达克股票代码:SLRX)股价上涨33.05%,至1.57美元。截至美国东部标准时间 12:30,Salarius Pharmicals的股票交易量为240.1万股。这是其过去 100 天平均全日交易量的478.2%。该公司的市值为350万美元。
Losers
失败者
- Hoth Therapeutics (NASDAQ:HOTH) shares fell 25.4% to $8.0 during Friday's regular session. Trading volume for Hoth Therapeutics's stock is 4.7 million as of 12:30 EST. This is 798.3% of its average full-day volume over the last 100 days. The company's market cap stands at $10.4 million.
- Nuwellis (NASDAQ:NUWE) stock fell 16.92% to $10.07. As of 12:30 EST, Nuwellis's stock is trading at a volume of 405.9K, which is 184.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 million.
- Revelation Biosciences (NASDAQ:REVBU) shares declined by 16.67% to $0.2.
- Reshape Lifesciences (NASDAQ:RSLS) shares decreased by 16.28% to $6.43. Reshape Lifesciences's stock is trading at a volume of 81.1K shares as of 12:30 EST. This is 285.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million.
- Summit Therapeutics (NASDAQ:SMMT) shares fell 13.38% to $4.6. As of 12:30 EST, this security is trading at a volume of 3.1 million shares, making up 37.6% of its average full-day volume over the last 100 days. The company's market cap stands at $926.0 million.
- Femasys (NASDAQ:FEMY) stock fell 13.15% to $0.72. The market value of their outstanding shares is at $8.5 million. See Also:
- Hoth Therapeu 纳斯达克股票代码:HOTH)股价在周五的例行交易中下跌25.4%,至8.0美元。截至美国东部标准时间 12:30,Hoth Therapeutics股票的交易量为470万股。这是其过去 100 天平均全日交易量的798.3%。该公司的市值为1,040万美元。
- Nuwellis 纳斯达克股票代码:NUWE)股价下跌16.92%,至10.07美元。截至美国东部标准时间 12:30,Nuwellis的股票交易量为405.9K,占其过去100天平均全日交易量的184.8%。他们已发行股票的市值为310万美元。
- 启示录生物科学 纳斯达克股票代码:REVBU)股价下跌16.67%,至0.2美元。
- 重塑生命科学 纳斯达克股票代码:RSLS)股价下跌16.28%,至6.43美元。截至美国东部标准时间 12:30,Reshape Lifesciences的股票交易量为81.1万股。这是其过去 100 天平均全日交易量的285.1%。该公司的市值为310万美元。
- 峰会疗法 纳斯达克股票代码:SMMT)股价下跌13.38%,至4.6美元。截至美国东部标准时间 12:30,该证券的交易量为310万股,占其过去100天平均全日交易量的37.6%。该公司的市值为9.26亿美元。
- Femasys 纳斯达克股票代码:FEMY)股价下跌13.15%,至0.72美元。他们已发行股票的市值为850万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!